Vai al contenuto principale della pagina

How selegiline ((-)-deprenyl) slows brain aging [[electronic resource] /] / authored by Joseph Knoll



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Knoll J (József) Visualizza persona
Titolo: How selegiline ((-)-deprenyl) slows brain aging [[electronic resource] /] / authored by Joseph Knoll Visualizza cluster
Pubblicazione: [s.l], : Bentham Science Publishers, 2012
Descrizione fisica: 1 online resource (161 p.)
Disciplina: 616.8527
Soggetto topico: Depression, Mental
Brain - Aging
Selegiline
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references and indexes.
Nota di contenuto: Cover; Title; EUL; Contents; Foreword; Abbreviations; Keywords; Introduction; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chapter 09; Summary and Conclusion; Epilogue; References; Appendix; Author Index; Subject Index
Sommario/riassunto: This e-book is a reference on Selegiline ((-)-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug. ((-)-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyra
Titolo autorizzato: How selegiline ((-)-deprenyl) slows brain aging  Visualizza cluster
ISBN: 1-60805-470-5
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910785919303321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui